share_log

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga ·  Apr 25 12:31

Gainers

  • Aclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million.
  • Processa Pharma (NASDAQ:PCSA) stock moved upwards by 43.18% to $2.32. The market value of their outstanding shares is at $6.6 million.
  • Akso Health Group (NASDAQ:AHG) shares moved upwards by 29.87% to $1.0. The market value of their outstanding shares is at $109.5 million.
  • Eyenovia (NASDAQ:EYEN) shares increased by 22.87% to $0.72. The company's market cap stands at $33.9 million.
  • Predictive Oncology (NASDAQ:POAI) stock increased by 21.64% to $1.63. The company's market cap stands at $6.6 million.
  • IMAC Hldgs (NASDAQ:BACK) shares moved upwards by 18.93% to $4.14. The market value of their outstanding shares is at $4.7 million.

Losers

  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock declined by 33.1% to $1.54 during Thursday's regular session. The market value of their outstanding shares is at $2.0 million.
  • Organogenesis Hldgs (NASDAQ:ORGO) stock decreased by 22.32% to $2.31. The market value of their outstanding shares is at $305.4 million.
  • Xylo Technologies (NASDAQ:XYLO) shares decreased by 16.35% to $1.74. The market value of their outstanding shares is at $3.2 million.
  • Protagenic Therapeutics (NASDAQ:PTIX) stock declined by 14.31% to $1.4. The market value of their outstanding shares is at $6.2 million.
  • American Oncology Network (NASDAQ:AONC) shares fell 14.14% to $3.95. The company's market cap stands at $41.8 million.
  • INVO Bioscience (NASDAQ:INVO) shares decreased by 13.68% to $1.01. The market value of their outstanding shares is at $2.7 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment